Compared to the non-lesional skin tissues, in BCC tissues without a STR mutation in BRAF, “Ras signaling pathway” genes were overexpressed on average by 1.41-fold (95% CI 1.29–1.54; see Figure 6A), whereas in BCC tissues, with a STR somatic mutation in BRAF, those same “Ras signaling” genes were more markedly overexpressed, by 2.47-fold (95% CI 2.22–2.75; see Figure 6B) (ANOVA interaction p = 2.29 × 10−25). This evidence concerns the gene BRAF and skin basal cell carcinoma.